Erschienen in:
01.07.2011 | General Gynecology
A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis
verfasst von:
Saeed Alborzi, Bahareh Hamedi, Azizeh Omidvar, Sedigheh Dehbashi, Soroosh Alborzi, Mehrnoosh Alborzi
Erschienen in:
Archives of Gynecology and Obstetrics
|
Ausgabe 1/2011
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To compare the role of an aromatase inhibitor (letrozole) with a GnRH agonist (triptorelin) versus case control on the pregnancy rate and recurrence of symptoms and signs in patients with endometriosis.
Methods
In a prospective randomized clinical trial, after treatment of 144 infertile women in their reproductive age by laparoscopy (whose endometriosis was confirmed by prior laparoscopy), they were divided into 3 groups: group 1 (47 cases) who received letrozole for 2 months, group 2 (40 patients) who were prescribed triptorelin for 2 months and group 3 who were 57 patients in the control group and did not receive any medication. We followed up each group at least for 12 months after their restoration of regular cycle.
Results
Pregnancy rate was 23.4% in group 1, 27.5% in group 2, and 28.1% in group 3. The results did not show significant differences among the 3 groups. Recurrence rate of endometriosis was 6.4% in group 1, 5% group 2 and 5.3% in group 3, which was not statistically significantly different as well.
Conclusion
Pregnancy rate and endometriosis recurrence rate are comparable among the 3 groups.